(NASDAQ: CRIS) Curis's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 13.19%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 17.73%.
Curis's earnings in 2025 is -$43,389,000.On average, 3 Wall Street analysts forecast CRIS's earnings for 2025 to be -$25,435,444, with the lowest CRIS earnings forecast at -$32,423,465, and the highest CRIS earnings forecast at -$19,861,494. On average, 2 Wall Street analysts forecast CRIS's earnings for 2026 to be -$25,633,210, with the lowest CRIS earnings forecast at -$25,972,723, and the highest CRIS earnings forecast at -$25,293,698.
In 2027, CRIS is forecast to generate -$18,461,004 in earnings, with the lowest earnings forecast at -$24,360,038 and the highest earnings forecast at -$12,561,971.